Association of quality-of-life outcomes in cancer drug trials with survival outcomes and drug class

JN Samuel, CM Booth, E Eisenhauer… - JAMA …, 2022 - jamanetwork.com
Importance Although quality of life (QOL) is an important clinical end point, cancer drugs are
often approved based on overall survival (OS) or putative surrogate end points such as …
被引用次数：26 相关文章

Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and Drug Class.

JN Samuel, CM Booth, E Eisenhauer, M Brundage… - JAMA …, 2022 - europepmc.org
Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and
Drug Class. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …
[HTML] nih.gov

[HTML][HTML] Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and Drug Class

JN Samuel, CM Booth, E Eisenhauer… - JAMA …, 2022 - ncbi.nlm.nih.gov
Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and Drug
Class - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and Drug Class

JN Samuel, CM Booth, E Eisenhauer… - JAMA …, 2022 - pubmed.ncbi.nlm.nih.gov
Importance Although quality of life (QOL) is an important clinical end point, cancer drugs are
often approved based on overall survival (OS) or putative surrogate end points such as …

Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and Drug Class.

JN Samuel, CM Booth, E Eisenhauer, M Brundage… - JAMA …, 2022 - europepmc.org
Association of Quality-of-Life Outcomes in Cancer Drug Trials With Survival Outcomes and
Drug Class. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …